Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Gastrointest Endosc. 2011 Jan;73(1):1-6. doi: 10.1016/j.gie.2010.08.049. Epub 2010 Nov 12.
Photodynamic therapy (PDT) has been found to be safe and effective in patients with small early esophageal squamous cell carcinoma (SCC). However, its efficacy for widespread superficial SCC has not yet been confirmed.
To assess the long-term survival, complications, and recurrence of PDT for large superficial esophageal SCC.
Retrospective study.
Tertiary referral center.
A total of 38 patients with superficial SCC of the esophagus. All patients had a large unifocal lesion or multifocal lesions that were too large to be resected endoscopically. In addition, all patients were physiologically unfit for esophagectomy or had refused surgery.
PDT with porfimer sodium.
Clinical follow-up, long-term survival, complications, and recurrence were evaluated.
Thirty-one patients (82%) had mucosal cancer (T1m), and 7 (18%) had submucosal cancer (T1sm). No patient had lymph node involvement. Nineteen patients had other primary malignancies. Complete remission was achieved in 33 (87%). At the time of writing, 28 patients (74%) were alive without recurrence. After a median follow-up period of 64 months (range, 7-125 months) after PDT, the overall 5-year survival rate was 76%. There was no treatment-related mortality.
Retrospective study with a small number of patients.
This long-term follow-up study revealed that PDT was a potentially curative treatment for large superficial esophageal SCC. PDT might be a reasonable alternative to esophagectomy or to endoscopic resection for patients with superficial SCC of the esophagus without lymph node metastasis.
光动力疗法(PDT)已被证实可安全有效地治疗小的早期食管鳞状细胞癌(SCC)。然而,其对广泛表浅 SCC 的疗效尚未得到证实。
评估 PDT 治疗大面积表浅性食管 SCC 的长期生存率、并发症和复发情况。
回顾性研究。
三级转诊中心。
38 例表浅性食管 SCC 患者。所有患者均有大的单发病变或因病变过大无法经内镜切除的多灶性病变。此外,所有患者均因生理原因不适合接受食管切除术或拒绝手术。
应用卟啉钠行 PDT。
临床随访、长期生存率、并发症和复发情况。
31 例(82%)患者为黏膜癌(T1m),7 例(18%)患者为黏膜下癌(T1sm)。无患者有淋巴结受累。19 例患者存在其他原发性恶性肿瘤。33 例(87%)患者达到完全缓解。截至撰写本文时,28 例(74%)患者无复发且存活。PDT 后中位随访 64 个月(7-125 个月),总 5 年生存率为 76%。无治疗相关死亡。
回顾性研究,患者数量较少。
这项长期随访研究表明,PDT 可能是治疗大面积表浅性食管 SCC 的一种有潜力的治愈性治疗方法。对于无淋巴结转移的表浅性食管 SCC 患者,PDT 可能是食管切除术或内镜下切除的合理替代方法。